Scythian Shares Update for US Expansion

- October 11th, 2018

Scythian Biosciences announced the Florida Department of Health Office of Medical Marijuana Use approved its equity transfer of 3 Boys Farms to CannCure investments.

Scythian Biosciences (CSE:SCYB) announced the Florida Department of Health Office of Medical Marijuana Use (DOH) approved its equity transfer of 3 Boys Farms to CannCure investments.

As quoted in the press release:

As part of the transaction, the DOH has also approved the initial transfer of the first 60 [percent] of equity from 3 Boys Farms to CannCure and the remaining balance of 40 [percent] will close as soon as possible, subject to the receipt of all required governmental approvals from the DOH.

“This is a major milestone in the rollout of our U.S. expansion,” said Scythian CEO Brady Cobb. “It’s an important part of the strong presence we are building in the burgeoning U.S. cannabis industry, with Florida representing one of the most coveted markets to be a licensed operator in.”

Click here to read the full press release.

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time

Tags

Tags: , ,

Leave a Reply

Your email address will not be published. Required fields are marked *